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Abstract
Synergistic combinations of antimicrobial agents with different mechanisms of action have
been introduced as more successful strategies to combat infections involving multidrug re-
sistant (MDR) bacteria. In this study, we investigated synergistic antimicrobial activity of Ca-
mellia sinensis and Juglans regia which are commonly used plants with different
antimicrobial agents. Antimicrobial susceptibility of 350 Gram-positive and Gram-negative
strains belonging to 10 different bacterial species, was tested against Camellia sinensis and
Juglans regia extracts. Minimum inhibitory concentrations (MICs) were determined by agar
dilution and microbroth dilution assays. Plant extracts were tested for synergistic antimicro-
bial activity with different antimicrobial agents by checkerboard titration, Etest/agar incorpo-
ration assays, and time kill kinetics. Extract treated and untreated bacteria were subjected
to transmission electron microscopy to see the effect on bacterial cell morphology. Camellia
sinensis extract showed higher antibacterial activity against MDR S. Typhi, alone and in
combination with nalidixic acid, than to susceptible isolates.”We further explore anti-staphy-
lococcal activity of Juglans regia that lead to the changes in bacterial cell morphology indi-
cating the cell wall of Gram-positive bacteria as possible target of action. The synergistic
combination of Juglans regia and oxacillin reverted oxacillin resistance of methicillin resis-
tant Staphylococcus aureus (MRSA) strains in vitro. This study provides novel information
about antimicrobial and synergistic activity of Camellia sinensis and Juglans regia against
MDR pathogens
Introduction
The increase of infections involving multidrug-resistant (MDR) bacteria and of resistance to
last resort antimicrobial agents have limited therapeutic options of bacterial infections.
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According to the World Health Organization, infectious diseases are the third most signifi-
cant cause of mortality around the world (http://www.who.int/mediacentre/factsheets/fs310/
en/index2.html). The burden of infectious diseases is high in developing countries, as is the
emergence of MDR pathogens due to poor health-care facilities, and over-the-counter avail-
ability and misuse of antimicrobial agents [1,2]. The frequency of resistance is observed equally
among Gram-negative and Gram-positive organisms, although Gram-negative bacteria are
prone to develop a MDR phenotype. The high incidence rate of MDR Pseudomonas and Acine-
tobacter infections in critically ill patients as well as the presence of MDR Salmonella and
Staphylococcus aureus in normal communities are classic examples of microbiological chal-
lenges posed in these geographic locations [3,4,5,6].
In the last fifty years, only two novel classes of antimicrobial compounds such as oxazolidi-
none and cyclic lipo-peptide have passed clinical trials and are available for clinical use. These
agents have undergone analogue development and six drugs were introduced in market in the
last decade; however, they are not useful for MDR pathogens due to the rapidly evolving mech-
anisms of resistance among bacteria [7,8]. Most other compounds do not proceed to clinical
trials due to lack of sustained activity and higher toxicity rates. It is clearly understood that
progress in the field of drug discovery is far behind what is required to keep up with present
day needs. The situation necessitates the development of new antimicrobial agents in
rapid fashion.
Plants are historically used to treat infectious diseases. In earlier days people used to discov-
er remedies from the local herbs. People first used plants as food and if results of ingestion
were favorable, the plants were linked with some sedative and curative properties. For example,
remains of the hollyhock plant, which is still an important herb in phytomedicine, are found in
the ancient civilization of the Neanderthals [9]. Scientific evidence supports the hypothesis that
several plants are composed of biologically active chemical entities and several drugs in modern
day medicine are actually analogues of plant origin substances [10,11,12]. In this study, we
aimed to screen the antibacterial activity of Camellia sinensis (green tea) and Juglans regia,
which are commonly used in the Pakistani population. Aqueous and methanolic preparations
of plant extracts were tested for antibacterial activity against a wide variety of pathogens alone




A total of 350 Gram-positive and Gram-negative strains were obtained from the culture reposi-
tory of the Immunology and Infectious Diseases Research Laboratory, Department of Microbi-
ology, University of Karachi. Bacterial strains were of clinical and environmental origins
(Tables 1 and 2). Clinical strains were isolated from urine, stool, wound, sputum and blood
samples, submitted to several pathological laboratories of Karachi for microbiological culture
and sensitivity. Environmental isolates were obtained from the culture collection of Depart-
ment of Microbiology, University of Karachi. Reference strains included S. aureus ATCC
25923, Escherichia coli ATCC 25922, Salmonella enterica serovar Typhi ATCC 13311, and Shi-
gella flexneri ATCC 9199. Biochemical identification and antimicrobial susceptibility was per-
formed as described previously [13] and antimicrobial susceptibility data were interpreted
according to standard breakpoints described by clinical and laboratory standard institute
(CLSI) criteria for each antimicrobial agents [14]. The origin and resistance pattern of these
bacterial isolates are given in S1 Table. Isolates were stored in Luria-Bertani (LB) broth
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containing 50% glycerol at -80°C. Log phase bacterial cultures grown in LB broth were used for
antibacterial assays.
Preparation of plant extracts
Plant material included the dried leaves of Camellia sinensis (green tea) and the bark of Juglans
regia (locally referred to as dandasa). The samples were purchased from a local market and
identified by Ms. Muneeba Khan, the designated plant taxonomist of the Department of Bota-
ny, University of Karachi, Pakistan. Plant material was ground to a powder in a mechanical
grinder. Five percent (w/v) aqueous infusion of plant material was prepared in sterile ultrapure
laboratory grade water by three successive cycles of heating at 80°C for three minutes. The so-
lutions were filtered using 0.22μmmembrane [15]. For methanolic extracts, plant material was
soaked into 95% methanol in a ratio of 1: 10 (w/v) for 72 hours at 22°C with vigorous shaking.
The extract was subjected to methanol evaporation under vacuumed pressure and residual ma-
terial was considered as source of methanolic extract. Stock solutions were prepared in DMSO
Table 1. Antimicrobial activity of Camellia sinensis.
Organisms Origin R-type n Camellia sinensis (green tea)
Aqueous Methanolic
Zone (mm) MIC mg/ml MBC mg/ml Zone (mm) MIC mg/ml MBC mg/ml
Staphylococcus aureus Clinical S 40 17 0.78 1.56 20 0.39 1.56
Staphylococcus aureus Clinical MRSA 99 17 0.19 1.56 20 0.39 1.56
Streptococcus pyogenes Clinical S 05 17 0.78 1.56 ND ND ND
Escherichia coli Clinical S 125 07 3.12 5.0 06 5 >5
Salmonella enterica serovar Typhi Clinical MDR 16 06 1.56 1.56 06 1.25 2.5
Salmonella enterica serovar Typhi Clinical S 22 06 3.12 3.12 06 2.5 2.5
Pseudomonas aeuginosa Clinical MDR 02 06 >5 >5 06 >5 >5
Acinetobacter buamannii Clinical MDR 01 06 >5 >5 06 >5 >5
Klebseilla pneumoniae Clinical MDR 01 06 3.12 5.0 06 5 >5
Citrobacter freuendii Clinical MDR 01 06 3.12 5.0 06 5 >5
Enterobacter cloacae Clinical MDR 01 06 3.12 5.0 06 5 >5
Bacillus subtilis Env. S 02 17 0.78 1.56 20 0.78 1.56
Streptococcus pneumoniae Clinical S 01 12 1.56 3.12 20 0.78 3.12
Micrococcus Env. S 01 13 0.78 1.56 20 0.39 1.56
Salmonella Paratyphi A Clinical S 08 06 1.56 3.12 06 1.25 2.5
Shigella species Clinical S 15 06 3.12 6.25 ND ND ND
Helicobacter pylori Clinical R A C 02 06 >5 >5 09 2.5 >5
Helicobacter pylori Clinical S 03 06 >5 >5 09 2.5 >5
Campylobacter jejuni Clinical S 05 06 >5 >5 06 >5 >5
S. aureus ATCC 25923, Reference 20 0.78 1.56 20 0.39 1.56
Escherichia coli ATCC 25922, Reference 06 3.12 5.0 06 5 >5
Salmonella Typhi ATCC 13311, Reference 06 3.12 3.12 06 2.5 2.5
Shigella ﬂexneri ATCC 9199 Reference S 06 >5 >5 06 2.5 >5
S_ pan susceptible; MRSA_ Methicillin resistance Staphyococcus aureus; MDR_ Multidrug resistant; MIC_ minimum inhibitory concentration; MBC_
minimum bactericidal concentration; Env._ environmental; R-type_ Resistance phenotype; n_number of isolates; zone_diameter of zone of inhibition; R A
C_Rifampicin Ampicillin Chloramphenicol.
doi:10.1371/journal.pone.0118431.t001
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(Merck, Darmstadt, Germany)) and final working volumes were achieved by diluting the stock
into Muller Hinton (MH) broth (Oxoid, Hamshire, UK).
Antimicrobial susceptibility assays
A total of 350 bacterial strains (Tables 1 and 2) were subjected to antimicrobial susceptibility
and MIC assays. In addition, reference strains such as S. aureus ATCC 25923, Escherichia coli
ATCC 25922, Salmonella enterica serovar Typhi ATCC 13311, and Shigella flexneri ATCC
9199 were run each time as control for susceptibility and MIC assays. Plant extracts were
screened for antimicrobial activity using the agar well diffusion method. Bacterial cultures were
inoculated in LB broth for 3 hours at 37°C and turbidity was adjusted in phosphate buffered sa-
line (PBS) to 0.5 McFarland’s index. Using a sterile cotton swab, a bacterial lawn was spread on
90 mmMHA plates containing 6mm wells. Twenty microliters of plant extracts were poured
into each well and plates were incubated at 37°C aerobically for 18 hours. Columbia blood agar
plates containing 7% lake horse blood (Oxoid, Hamshire, UK) provided a platform for Helico-
bacter and Campylobacter based assays. Plates were incubated in microaerophilic conditions
using a Campygen kit (Oxoid, Hamshire, UK) at 37°C for 48 hours. The diameter of the zone
of bacterial inhibition around each well was measured [16].
Minimum inhibitory concentrations (MICs) were determined by agar dilution and micro-
broth dilution assays using MH agar and MH broth respectively [17]. The concentrations of
the extracts tested ranged from 5000 to 50μg/ml. In the case of agar dilution, experiments were
performed on MH agar plates containing various concentrations of extracts (1:20 v/v). Plates
were inoculated with ten microliters of the test organism containing 105 CFU log phase bacte-
ria per spot and a total of 20 spots were tested on one plate. In the case of the microbroth
Table 2. Antimicrobial activity of Juglans regia.
Organisms Origin R-type N Juglans regia
Aqueous Crude Methanol
Zone mm MIC mg/ml MBC mg/ml Zone mm MIC mg/ml MBC mg/ml
Staphylococcus aureus Clinical MRSA 99 23 0.31 0.6 28 0.31 1.06
Staphylococcus aureus Clinical S 40 >20 1.25 2.5 18 0.53 1.06
Bacillus subtilis Env. S 01 20 0.78 2. 5 19 1.06 2.5
Micrococcus Env. S 01 19 0.78 1.56 19 0.78 1.56
Escherichia coli Clinical S 123 06 >5 > 5 06 1.06 2.1
Salmonella enterica serovar Typhi Clinical MDR, S 38 13 >5 > 5 06 >5 >5
Pseudomonas aeruginosa Clinical MDR 2 06 >5 > 5 06 >5 >5
Streptococcus pyogenes Clinical S 05 15 1.25 5 12 1.25 5
Streptococcus pneumonia Clinical S 01 06 >5 >5 12 1.25 5
Shigella species Clinical S 15 06 2.5 >5 06 >5 >5
Enterobacter cloacae Clinical MDR 01 06 5 >5 06 >5 >5
Pasteurella multocida. Clinical S 02 15 1.25 5 09 2.5 5
Helicobacter pylori Clinical R A C 02 06 >5 >5 09 >5 >5
Helicobacter pylori Clinical S 03 06 >5 >5 09 >5 >5
Campylobacter jejuni Clinical S 05 06 >5 >5 06 >5 >5
S_ pan susceptible; MRSA_ Methicillin resistance Staphyococcus aureus; MDR_ Multidrug resistant; MIC_ minimum inhibitory concentration; MBC_
minimum bactericidal concentration; Env._ environmental; R A C_ Rifampicin Ampicillin Chloramphenicol; R-type_ Resistance phenotype; n_number of
isolates; zone_diameter of zone of inhibition
doi:10.1371/journal.pone.0118431.t002
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dilution assay, sterile flat-bottom 96-well plates were loaded with 100μl of two-fold dilutions of
extracts into each well. The starting bacterial inoculum was 1.5x105 CFU/ml. Plates without
any plant extracts were served as growth control. The assay plates were incubated as described
above. The highest dilution of extract that showed no visible bacterial growth per spot and no
turbidity in agar dilution and microbroth dilution assay respectively was considered as MIC.
To determine minimum bactericidal concentration (MBC) of extracts, 100μl of MH broth
from each well of microbroth assay was sub-cultured on MH agar plates after 24 hours of initial
incubation. MH plates were incubated for another 24 hours. The lowest concentration of ex-
tract that resulted in no bacterial growth was considered as MBC. Experiments were performed
in quadruplicate on five different occasions.
Synergistic antimicrobial assays
Antimicrobial activity of plant extracts in the presence of different antimicrobial agents, such as
oxacillin, tetracycline, nalidixic acid, ofloxacin, chloramphenicol, gentamicin and penicillin was
determined. The details about the preprartion of antimicrobial agents are provided in S2 Table.
Camellia sinensiswas tested against representative strains of Salmonella enterica serovar Typhi
(n = 16) while Juglans regia extract was tested against Staphylococcus aureus (n = 21). Each com-
bination was first tested by the checkerboard titration method using MH broth in microtiter
plates as described previously [18]. Concentrations of extracts ranged from 5000 to 5 μg/ml. The
antimicrobial activity of the extract and antibiotic combination was interpreted as one of the fol-
lowing categories: Synergy; indifferent; additive effect; or antagonism. The fractional inhibitory
concentration (FIC) of each agent was calculated as the MIC of the agent in combination, divided
by the MIC of the agent alone. The interpretation was made on the basis of the fractional inhibi-
tory concentration index (SFIC), which is the sum of the FICs of both agents. The FICI results
were interpreted as follows:< 0.5 synergy; 0.5 to 1 additive effect; 1–2 indifferent or no effect;
and>2 antagonism [19]. Synergistic combinations were further checked using the Etest/agar in-
corporation assay [20] in which an Etest-strip of each respective antimicrobial agent was placed
on MH agar plates containing FIC and 0.5 x FIC of each extract. MH plates containing no anti-
microbial agent or extract served as growth control. Plates were incubated at 37°C for 16 hours.
Breakpoint values for the resistance of antimicrobial agents were defined per standard criteria.
Time kill kinetic assay
Time kill kinetic assays were performed on successful synergistic combinations obtained by
Etest-strip and checkerboard titration methods. Flasks containing 100 ml MH broth and the
drug-plant extract combination were inoculated with a log phase culture of the test organism
to a density of 1 x 105 CFU/ml. Test strains included Salmonella enterica serovar Typhi (n =
16) and Staphylococcus aureus (n = 21). Individual components of each combination, either ex-
tract or antibiotic, were added to the control flask to compare the effects of the synergistic com-
binations to their individual effects on the bacterial growth curve, while no drug was added to
the growth control flask. Flasks were incubated for 24 hours at 37°C. Aliquots (100μl) were col-
lected at different time intervals from each flask, serially diluted in PBS, and cultured onMHA
plates to obtain colony counts [21]. Curves were constructed by plotting the log10 of CFU/ ml ver-
sus time. Synergy was defined as2 log10 decreases in CFU of organisms treated with the drug
combination compared to the most active component of the alone as described previously [22].
Transmission electron microscopy
On the basis of biological activity, bacterial strains treated with sub-inhibitory concentrations
(0.5 x MIC) of Camellia sinensis and Juglans regia extracts were subjected to transmission
Synergistic Antimicrobial Activity of Plant Extracts
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electron microscopy to see their effects on bacterial cell morphology as previously described
protocol with some modifications [23]. Test organisms (S. aureus n = 21) were grown in 10ml
of MH broth containing sub-inhibitory concentrations (0.5 X MIC) of plant extracts, at 37°C
for 18 hours. Broth was centrifuged at 5000 x g and pellets were washed twice with PBS, fixed
with gluteraldegyde and OsO4, dehydrated in graded ethanol and resuspended in 500μl PBS.
Formvar coated 300-mesh copper grids were coated with 5μl sample suspension for 10 min
with the help of sterile tweezers and rinsed once with sterile MilliQ water to remove excessive
non-coated material. Copper grids were locally made by the mechanical engineering depart-
ment of the N. E.D. University of engineering, Karachi. Negative staining was performed by
immersing coated grids in 1% uranyl acetate for 20 seconds followed by destaining in sterile
MilliQ water and air drying. Grids were observed directly with a JOEL CO-Japan’s JEM 100
transmission electron microscope operating at 80 kV.
Results
Antimicrobial activity of Camellia sinensis extracts
Susceptibility studies showed that Camellia sinensis (green tea) extracts have higher antimicro-
bial activity against multidrug resistant Salmonella Typhi and sensitive Salmonella Paratyphi A
than other Gram-negative isolates (Table 1). The S. Typhi strains (n = 16) with phenotypes re-
sistant to ampicillin (Amp), tetracycline (T), streptomycin (S), co-trimoxazole (Sxt), nalidixic
acid (Na), and ciprofloxacin (Cip) were inhibited by 1.25mg/ml of methanolic and 1.56mg/ml
of aqueous extract of green tea. The respective MIC/MBC ratio was 1 and 0.5, and MICs were
higher to pan-susceptible strains, however no activity (only 6 mm zone of inhibition) was ob-
served around by agar well diffusion assay. The difference in the data obtained by these assays
could be explained by the presence of high molecular weight bioactive compounds which are not
readily absorbed and move through solidified agar medium. Time kill kinetics further explained
the bacteriostatic effect of green tea extracts on S. Typhi (Fig. 1A). No significant antimicrobial
activity was observed in other Gram-negative and microaeophilic organisms such as Pseudomo-
nas aeruginosa, Escherichia coli, Acinetobacter buamannii, Klebseilla pneumoniae, Citrobacter
freundii and shigella species. Although the MIC of aqueous extract was 3.12 mg/ml, they were not
considered active due to higher MIC values in methanolic extract and no activity by agar well dif-
fusion assay. Green tea was found to be very active against Gram-positive organisms, including
Staphylococcus aureus,Microccocus, Streptococcus pneumonia and Bacillus subtilis. The methano-
lic extract inhibited the growth of S. aureus with a 20mm zone of inhibition and an average MIC
of 0.39 mg/ml andMBC 1.56 mg/ml. Although insignificant, MICs of aqueous extracts were
lower for methicillin-resistant Staphylococcus aureus (MRSA) compared to sensitive reference
and clinical strains of S. aureus (Table 1 and S3 Table). Dose dependent cidal effect was observed
against drug-resistant and sensitive strains on 24 and 6 hours respectively (Fig. 1B and 1C).
Antimicrobial activity of Juglans regia extracts
The most potent inhibitory effect of Juglans regia extracts was observed on MRSA strains with
MICs 0.31 mg/ml and a zone of inhibition of more than 20 mm around aqueous and methano-
lic extracts (Table 2). Interestingly, two- to four-fold increases in MIC were found when drug-
sensitive clinical strains of S. aureus were tested, but the MIC/MBC ratio was 0.5 in both cases.
In contrast with green tea, Juglans regia did not show activity with Gram-negative bacteria;
only E. coli was found to be susceptible at 1.06 mg/ml of methanolic extract with no zone of in-
hibition. Time kill kinetics showed a dose dependent bactericidal effect on methicillin-resistant
and sensitive S. aureus strains, indicating strong anti-staphylococcal activity of Juglans regia ir-
respective of the spectrum of resistance against other antimicrobial agents (Fig. 2). Our data
Synergistic Antimicrobial Activity of Plant Extracts
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clearly indicate strong antimicrobial activity of Juglans regia against Gram-positive organisms,
particularly Staphylococcus species.
Synergistic activity of plant extracts with antimicrobial agents
A number of antibiotic combinations were checked with synergistic activity of Camellia sinen-
sis and Juglans regia extracts and two different combinations showed strong synergistic activity
(Table 3). When Camellia sinensis was combined with nalidixic acid, it was able to inhibit S.
Typhi at sub-MIC levels. We also observed a significant reduction in MICs of nalidixic acid,
which explains the strong synergy (FICI 0.37) in this combination (Table 3). However, the
MICs of nalidixic acid did not reach breakpoint level (8μg/ml) for the MDR strain (R type-
Amp C Sxt T Na). Time kill kinetics showed synergy at 2, 4, 6 and 8 hours (Fig. 3A).
In the case of Juglans regia, 10 times reduction in MICs was observed against Staphylococcus
aureus when used in combination with oxacillin. In this combination, oxacillin was able to in-
hibit MRSA strains at 0.312μg/ml, which was 64 times lower than the MIC of oxacillin alone
and indicates a reversion of methicillin resistance if used along with Juglans regia. In time kill
kinetics, the Juglans regia and oxacillin combination exhibited synergy at 3, 4, 5, 8 and 9 hours
in 10/10 MRSA strains (Fig. 3B). A complete cidal effect was observed in 9 hours, which per-
sisted to 24 hours of incubation.
Effect on bacterial cell morphology
Transmission electron microscopy showed characteristic morphological changes in MRSA
after receiving treatment with Juglans regia extract for 18 hours. In contrast with untreated
Fig 1. Effect of Camellia sinensis on bacterial growth kinetics. Representative bacterial strains of (a) Salmonella enterica serovar Typhi, (b) Methicillin
resistant Staphylococcus aureus (MRSA), and (c) S. aureus ATCC 25923 (pan—susceptible) were treated with graded concentrations of methanolic extract
of Camellia sinensis (green tea). Growth cycle of untreated organisms served as growth control. A 2 Log10 decrease at any time point from original CFU was
considered as significant. Results are presented as an average for three experiments.
doi:10.1371/journal.pone.0118431.g001
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growth control (Fig. 4A), thick intracellular masses were observed in bacterial cells treated with
Juglans regia (Fig. 4B) that further led to the deformation of bacterial cells (Fig. 4C and 4D);
however, we did not find complete deformation of the cell. We also observed that Juglans
regia-treated deformed bacteria were coated with thread-like material, indicating the presence
of extract on the cellular surface (Fig. 4). Prominent changes in bacterial cell morphology indi-
cate that bacterial cell membrane permeability and viscosity was compromised by the Juglans
regia extract.
Discussion
Camellia sinensis belongs to the family Theaceae of tea plants. It is widely cultivated in tropical
and subtropical regions all over the world. Previous studies reported the antimicrobial activity
of green tea leaves to Gram-positive organisms [24,25,26]; however, discrepancies were found
regarding its activity in relation to Gram-negative rods [27,28,29]. In this study, we observed
that Camellia sinensis showed higher antibacterial activity against MDR S. Typhi than to other
Gram-negative isolates. By testing a variety of clinical strains in a time kill kinetic assay, we fur-
ther showed that green tea extract is bacteriostatic in nature and more efficient against MDR
strains of S. Typhi compared to pan-susceptible strains. Previous studies have reported that tea
catechins are bioactive components present in green tea particularly they are active against
Gram positive bacteria[30,31], however none of them is seen to be antimicrobial against Gram
negative bacteria. To the best of our knowledge this is the first report providing strong evidence
of the antimicrobial activity of green tea against drug-resistant Gram-negative bacteria.
Fig 2. Effect of Juglans regia on bacterial growth kinetics. (a) Methicillin resistamt Staphylococcus
aureus (MRSA) and (b) S. aureus ATCC 25923 (pan—susceptible) were treated with graded concentrations
of aqueous extract of Juglans regia (Dandasa). Growth cycle of untreated organisms served as growth
control. A 2Log10 decrease at any time point from original CFU was considered as significant. Results are
presented as an average for three experiments.
doi:10.1371/journal.pone.0118431.g002
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Juglans regia (walnut tree) is a common temperate forest tree found in Asia. The dried bark
of this treeis traditionally used in Pakistan to improve oral hygiene and promote teeth bright-
ening. The tree is rich in polyphenols and in previous studies the antimicrobial activity of this
plant was reported against bacteria and fungi [32,33,34]; however, these studies were focused
on the tree’s leaves instead of the bark. In this study, we tested Juglans regia bark extracts
against a wide range of bacterial pathogens and susceptibility data showed that the extract is se-
lectively active against Gram-positive bacteria. We observed strong anti-staphylococcal activity
of Juglans regia that led to the changes in bacterial cell morphology. The study suggests that
Juglans regiamight affect how metabolic processes occur in bacterial cell walls and cell mem-
branes. In contrast with the findings of Nariman et al. [35], no activity was observed against
microaerophilic organisms such asHelicobacter and Campylobacter. The observations warrant
further investigation for the search of compound(s) present in Juglans regia bark that leads to
the development of novel antimicrobial agent.
In this study, we investigated antimicrobial activity of plant extracts by several methods in-
cluding agar well diffusion, agar dilution and microbroth dilution assays. Significant differ-
ences were not observed in the MICs of Camellia sinensis and Juglans regia extracts obtained
by agar dilution and microbroth dilution methods. However the growth of certain strains
was not inhibited by agar well diffusion assay. Given that the assay was performed with
crude extract, we hypothesize that presence of high molecular weight components might hin-
der in the uniform distribution and movement of bioactive compound through solidified
agar medium.
Table 3. Synergistic antimicrobial activity of plant extracts with different antimicrobial agents.





Alone combination alone combination
Salmonella enterica serovar Typhi AmpCSxtTNa 3 Chloramphenicol 512 256 2.5 2.5 1.5 Indifferent
Tetracyclin 1 0.5 2.5 2.5 1.5 Indifferent
Nalidixic acid 256 32 2.5 0.62 0.37 Synergistic
Amp C Sxt T 7 Nalidixic acid 8 1 2.5 0.62 0.37 Synergistic
Pan-susceptible 6 Nalidixic acid 0.5 0.12 2.5 1.25 0.74 Additive
Tetracyclin 0.25 0.25 2.5 1.25 1.5 Indifferent
Chloramphenicol 2 2 2.5 0.75 1.3 Indifferent
MIC of Juglans regia
(mg/ml)
Staphylococcus aureus MRSA 15 Gentamicin 32 16 0.31 0.31 1.5 Indifferent
Penicillin 4 1 0.31 0.15 0.7 Additive
Oﬂoxacin 16 16 0.31 0.31 2 Indifferent
Oxacillin 20 0.312 0.31 0.039 0.14 Synergistic
Tetracycline 64 64 0.31 0.96 4 Antagonism
Pan-susceptible 6 Gentamicin 2 2 1.25 1.25 2 Indifferent
Penicillin 0.05 0.02 1.25 0.65 0.92 Additive
Oﬂoxacin 0.25 0.25 1.25 1.25 2 Indifferent
Oxacillin 0.5 0.312 1.25 0.37 0.92 Additive
Tetracycline 1 1 1.25 2.5 3 Antagonism
FICI_ fractional inhibitory concentration index; R-type_ Resistance phenotype; n_number of isolates; zone_diameter of zone of inhibition; MIC_ minimum
inhibitory concentration
doi:10.1371/journal.pone.0118431.t003
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Although the antimicrobial activity of these plants has been previously reported, little is
known about their interaction with antimicrobial agents which are commonly prescribed to
treat MDR bacterial infections. Here we tested the synergistic activity of Camellia sinensis and
Juglans regia extracts with a wide range of antimicrobial agents. Camellia sinensis showed syn-
ergistic activity with nalidixic acid (FICI 0.37) against MDR S. Typhi strains. Since Camellia
sinensis is bacteriostatic for Gram-negative rods, we hypothesize that this combination might
prevent the recurrence of bacterial growth caused by antibiotic selective mutants towards the
end of the disease’s course; therefore, it is worthwhile to test Camellia sinensis and its com-
pounds for synergistic activity with quinolones in vivo.
It was very surprising to see that Juglans regia was able to reverse oxacillin resistance in
MRSA. Oxacillin is a β-lactam antibiotic that inhibits cell wall peptidoglycan through binding
and competitive inhibition of penicillin binding proteins (PBPs) [36]. Activation ofmecA gene
and gene variants led to the formation of PBP2a, which binds with β-lactam antibiotics in lower
affinity, resulting in drug resistance[37,38]. Therefore, unavailability of PBP2a might resume an-
timicrobial action of oxacillin in MRSA strains. We have already shown that Juglans regia alone
induces ultrastructure changes inMRSA, indicating significant changes in the molecular machin-
ery of bacterial cells. We speculate that the addition of Juglans regiamight interfere in the synthe-
sis or transportation of PBP2a levels on the cell membrane. Previous studies also showed similar
effects on oxacillin resistance by different compounds such as phenothiazine, chloropromazine,
Fig 3. Effect of synergistic antimicrobial combinations on growth kinetics of MDR pathogens.
Synergistic antimicrobial combinations of (a)Camellia sinensis and nalidixic acid and (b) Juglans regia and
oxacillin were tested for antimicrobial effect on growth kinetics of MDRSalmonella enterica serovar Typhi and
Methicillin Resistant Staphylococcus aureus respectively. Organisms were grown inMH broth in the presence
of plants extracts alone and in combination with antibiotics and samples were taken for colony counts at
different time intervals. Control organisms were grown inMH broth only. A 2Log10 decrease at any time point
from original CFU was considered as significant. Results are given as average for three experiments.
doi:10.1371/journal.pone.0118431.g003
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thioridazine, inducing physiological damage to bacterial cell membranes [39,40]. Further studies
are warranted to understand the exact mechanism of action. This study is the first to report the
synergistic antimicrobial effects of Juglans regia in combination with β-lactam antibiotics leading
to the reversion of oxacillin resistance.
In a separate study, we tested these extracts for toxic effects on human RBCs. Camellia
sinensis was found to be non-toxic on the concentrations tested for antimicrobial activity while
Fig 4. Effect of Juglans regia on cell morphology of MRSA.Change in cellular morphology of MRSA was observed by Transmission Electron Microscopy,
A: Control cell, B-D shows bacterial cells treated with Juglans regia. B: Intracellular thick material. C: covering on unknownmaterial on cell surface. D: Hollow
and de-shaped bacteria.
doi:10.1371/journal.pone.0118431.g004
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Juglans regia showed toxicity at concentrations 100 times higher than the one showed antimi-
crobial activity (data not shown). The significant increase in toxic concentrations for human
RBCs demonstrates the feasibility of Jeglans regia to test for further bioactive compound
purification activities.
This study provides novel information about the antimicrobial potential of Camellia sinensis
and Juglans regia to MDR pathogens. Further studies investigating the mechanism of synergis-
tic action are important to prove candidacy of these substances for antimicrobial therapy.
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